Related Experiment Videos
Predicting the clearance of CYP2C9 substrates
Drug Metabolism and Disposition: the Biological Fate of Chemicals
|November 20, 2004
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Monitoring pharmacodynamic and molecular drug targets in liquid biopsy: Exploratory study in liver cancer with modelling of EGFR Receptor engagement.
British journal of clinical pharmacology·2026
Application of Virtual Twin PBPK Models in Individuals with Obesity via CYP3A4 Phenotyping Using Endogenous Biomarker Data.
Clinical pharmacology and therapeutics·2026
On pethidine: The 'accidental' opioid that became a 'model' analgesic agent.
Anaesthesia and intensive care·2026
Proteomic profiling of metabolizing enzymes and transporters in 2 layers of Caucasian human skin.
Drug metabolism and disposition: the biological fate of chemicals·2026
A Review of Virtual Twins in Physiologically-Based Pharmacokinetic Modeling and Simulation.
Clinical pharmacology and therapeutics·2026
PI3K-AKT-P-gp/Mrp2 signaling pathway drives the accelerated hepatic clearance of encapsulated docetaxel of PEGylated liposomes.
Drug metabolism and disposition: the biological fate of chemicals·2026
Role of CYP3A5 and CYP3A4 in the metabolism and toxicity of 10-hydroxyl mesaconitine, a new potential toxicity marker of Radix Aconiti Lateralis Preparata (Fuzi), in vitro and in vivo.
Drug metabolism and disposition: the biological fate of chemicals·2026
Prediction of pharmacokinetics and central nervous system effects of fentanyl and alfentanil in mice, rats, and humans using a cross-species physiologically based pharmacokinetic-pharmacodynamic model and in vitro pharmacokinetic/pharmacodynamic parameters.
Drug metabolism and disposition: the biological fate of chemicals·2026
Mechanistically resolved prediction of compound hepatotoxicity using primary human liver spheroids-Application to recent real-world cases.
Drug metabolism and disposition: the biological fate of chemicals·2026
CYP1A2 and ADH1C contribute to abacavir aldehyde intermediate formation in the human liver.
Drug metabolism and disposition: the biological fate of chemicals·2026
Investigation of biomarkers for azole antifungal-induced liver injury using primary human hepatocyte spheroids.
Drug metabolism and disposition: the biological fate of chemicals·2026